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Abstract Background Medication errors are common in
hospital inpatients. While many interventions have been
proposed to address these problems, few have been shown
to have significant benefits. A complementary approach is
to facilitate greater involvement of patients with their
inpatient medication. However, there is relatively little
research in this area and it is not known which interven-
tions lead to improved healthcare outcomes. Work is
therefore needed to investigate the roles that healthcare
professionals and patients believe are appropriate for hos-
pital inpatients to take relating to safety. Objective To
explore the extent to which hospital inpatients reported that
they engaged with medication safety-related behaviours,
the extent to which they would like to, and the extent to
which healthcare professionals reported that they would
support such engagement. Setting An NHS hospital Trust
in West London. Methods 100 Patients and healthcare
professionals were recruited on ten wards within the Trust
and invited to complete quantitative questionnaires. Data
were analysed descriptively and exploratory comparisons
made between different groups of respondents. Main out-
come measures inpatient medication safety involvement
scale and control preference scale for patient involvement
in decision making. Results 100 patients (98 % response
rate) and 104 healthcare professionals (59 % response rate)
were recruited. The majority of patients and healthcare
professionals were supportive of hospital inpatients being
involved with their medication. However there was a sig-
nificant gap between desire for patient involvement and
what patients reported having experienced. Female patients
and those under 65 wanted a significantly higher level of
involvement than males and over 65s. Few associations
were found between healthcare professionals’ reported
support for involvement and their profession or gender.
However, pharmacists and nurses were significantly more
likely to report supporting patients asking questions about
their medicines and self administering their own medicines
than doctors. Conclusion Healthcare professionals and
patients desire a higher level of patient involvement with
their medication while in hospital than patients currently
report. Interventions need to be developed to bridge the gap
between desired and actual patient involvement.
Keywords Hospital  Medication safety  Patient
participation  Shared decision making  United Kingdom
Impact of findings on practice
• The gap between patients’ preferred and experienced
involvement with inpatient medication needs to be
addressed.
• Healthcare professionals would support patients in
being involved with their medication while in hospital,
but they need to find ways to encourage this in practice.
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Introduction
The UK, USA and the World Health Organization [1–4]
have identified that priority should be given to improved
patient safety in healthcare. Medication error has been
shown to be one of the most frequent forms of medical
error and is associated with significant harm [5]. Medica-
tion errors are common in hospital inpatients. UK research
suggests that prescribing errors occur in up to 15 % of
inpatient medication orders, commonly involving omission
of patients’ usual medication on admission, and 9 % of
medications prescribed at discharge [6]. A recent meta-
analysis reports medication administration errors in 5.6 %
of non-intravenous doses and 35 % of intravenous doses
administered in the UK [7]. Although many of these do not
result in patient harm, others have more serious conse-
quences [8], and even errors which do not cause harm can
seriously affect the patient’s confidence in their healthcare.
While many interventions have been proposed to
address these problems, few have been shown to have
significant benefits [9]. A complementary approach, not yet
widely studied, is to facilitate greater involvement of
patients with their inpatient medication. In particular,
patients (and their carers) are likely to know a great deal
about medication that they have been using prior to
admission. Patients are therefore a potentially important
(and often the final) defence against errors relating to their
medication.
Patient safety activities relating to inpatient medication
include, but are not limited to, patients viewing their
inpatient medication records, prompting staff to avoid dose
omissions, providing information to aid handover between
shifts and professional groups, and raising queries with
prescribers, pharmacists or nursing staff. For example, in
one Swiss study, oncology patients detected errors such as
dose omissions [10]. Locally, observation of medication
administration rounds has confirmed that patients do query
their medication with ward staff, and sometimes prevent
potential medication errors [11]. However, our experience
also suggests that patients are often unsure of the medi-
cation they are prescribed as an inpatient, preventing
effective engagement with their treatment and thus a more
active role in medication safety. In particular, we have
observed considerable confusion among both patients and
hospital staff regarding whether or not hospital inpatients
are ‘permitted’ to look at their hospital medication records
where their current medication is prescribed and recorded.
Research has shown that patients are more willing to
participate in patient safety if encouraged to do so by
healthcare professionals [12–14]. However, there is rela-
tively little research in this area. A patient partnership
intervention has not shown a significant difference in
adverse drug effects between intervention and control
groups [15] and it is not known which interventions lead to
improved healthcare outcomes [16]. Further work is
therefore needed to investigate the roles that healthcare
professionals and patients believe are appropriate for hos-
pital inpatients to take relating to safety [17].
Aims of the study
In this paper we report the findings of a service evaluation
which aimed to explore the extent to which hospital inpa-
tients reported that they engaged with medication safety-
related behaviours, the extent to which they stated they
would like to, and the extent to which healthcare profes-
sionals reported that they would support such engagement.
Objectives
• To explore patients’ views on being involved in dif-
ferent aspects of their medication while in hospital.
• To explore healthcare professionals’ views on patients
being involved in different aspects of their medication
while in hospital.
• To explore whether views on patient involvement
might differ between different healthcare professions,
age groups and gender.
• To explore whether desired and reported patient
involvement differ among patient genders and age
groups.
• To identify any mismatches concerning views on
involvement between patients and healthcare
professionals.
• To identify any mismatches between the involvement
patients would like and their experienced involvement.
Methods
This exploratory survey was exempt from ethical review
and was approved as a service evaluation by the Quality
and Safety Committee of the study Trust.
Setting
The study took place in three hospitals of an NHS Trust in
West London in April and May 2013. There were a total of
82 wards in the Trust, each typically comprising about
20–25 beds. The Trust operated typical UK systems for
prescribing, dispensing and administration of medication.
Prescribing was paper-based, using pre-formatted drug-
charts on which nurses also recorded medication adminis-
tration. Commonly used medication was kept as ward stock
with other medication dispensed for individual patients.
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Patients were also encouraged to bring their own medica-
tion into hospital. Procedures were in place to allow
patients to self-administer medication where appropriate.
Pharmacists visited each ward on weekdays to check that
medication orders were clear, legal and clinically appro-
priate for each patient and to initiate the supply of any
medication needed.
Participants
We excluded wards thought likely to have a very high
proportion of unwell patients, as well as private wards.
Convenience sampling [18] was then used to recruit ten
wards from those remaining and then to identify patients
and healthcare professionals on the participating wards. We
studied a wide range of wards: gastroenterology, infectious
diseases, medical admissions, gastrointestinal surgery and
urology, trauma and orthopedics, elderly care rheumatol-
ogy and endocrine, urogynaecology, post-natal and two
stroke wards.
Healthcare professionals on participating wards assisted
with the identification of patients likely to meet our
inclusion criteria. Patients not speaking English, patients
judged by the healthcare professionals to be too unwell or
too cognitively impaired to participate and patients under
18 were excluded. The researcher (SMS) then approached
potentially suitable patients, provided them with a verbal
explanation of the study and offered a patient information
leaflet. Patients were able to take as much time as they
required to make a decision on whether to participate.
Completion of the questionnaire was taken as consent.
When visiting a ward, the researcher (SMS) approached
healthcare professionals on the ward at that time. All ward
pharmacists within the Trust were approached by email.
Respondents were given a brief explanation about the study
and offered further written information if required. Com-
pletion of the questionnaire was taken as consent.
The target sample size was 100 patients and 100
healthcare professionals to allow for exploratory compari-
sons between different genders, age groups and healthcare
professions.
Instruments
We used separate quantitative Questionnaires for health-
care professionals and patients (available online as sup-
plementary material). These both comprised two scales; the
first was developed for the present study, referred to as the
inpatient medication safety involvement scale (IMSIS).
The patient version comprised eight exploratory questions
about views on patient participation in their medication in
general while in hospital and medication safety in partic-
ular. The healthcare professional version had five questions
as we asked for their views only, and not their experiences.
We developed the IMSIS scale with reference to the lit-
erature [19–21] and in line with our research objectives.
The second was the three item control preference scale
[22], a validated instrument for measuring preferences for
involvement in healthcare decision making, as adapted by
Garfield et al. [23] to apply specifically to medication. The
questionnaire also included questions on gender, age, and
(for healthcare professionals) profession. The researcher
piloted the questionnaire on the participating wards with
nine healthcare professionals and five patients, and asses-
sed responses for face and content validity and accept-
ability. Following piloting, a question on whether or not
pharmacists were qualified independent prescribers was
amended very slightly to make it clearer. As no other
amendments were made, the pilot Questionnaires com-
pleted were included in the main study.
Data collection
The patients and healthcare professionals were presented
with the questionnaire on the ward by the researcher who
then collected the completed questionnaires. Respondents
were able to take as much time as they wanted to complete
the questionnaire. If a patient was unable to complete the
questionnaire themselves, the researcher offered to read the
questionnaire and complete it on their behalf. Question-
naires were also emailed to all the pharmacists working at
the Trust and emailed back to the researcher; one reminder
was sent 11 days later.
Data entry and analysis
Data were entered onto an SPSS (version 21) database
which was then cleaned. Descriptive quantitative data were
generated for all variables. We used Kreskas Wallis and
Mann–Whitney U tests to investigate whether there were
significant differences between the views of different
groups of healthcare professionals and between different
genders and age groups of patients and healthcare profes-
sionals. Wilcoxon tests were used to test whether there
were significant differences between patients’ preferred
involvement and the involvement they experienced. We
used Cronbach’s alpha to determine the internal reliability
of both our new instrument on participation in medication
safety (IMSIS) and the control preference scale [22, 23].
This provided information about whether or not it would be
appropriate to combine the individual items into a scale
and use summed scores for each of the two scales in further
analysis. We calculated Cronbach’s alpha separately for
patients and healthcare professionals’ data but did not sub-
divide healthcare professionals by profession as the num-
bers would have been too small for meaningful analysis.
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Where appropriate, we used Spearman’s bivariate corre-
lation to determine the strength of association between the
two scales.
While this was primarily a quantitative study, any
comments spontaneously added by respondents to the
questionnaire or stated verbally to the researcher that
informed the research objectives were recorded and ana-
lysed descriptively.
Results
Response rates
One hundred patients (98 % response rate), 24 doctors
(80 % response rate), 30 pharmacists (31 % response rate)
and 50 nurses (100 % response rate) took part. Demo-
graphic data for both patients and healthcare professionals
are presented in Table 1. The doctors who did not partic-
ipate reported that they were too busy. One patient who did
not participate reported that s/he was too tired and the other
that s/he did not want to be involved with the study.
Patients’ and healthcare professionals’ views
on inpatient involvement with medication, medication
safety and prescribing decisions
The majority of patients and healthcare professionals were
supportive of hospital inpatients being involved with their
medication. Table 2 shows the level of involvement that
patients both wished to have and actually reported having with
different aspects of their medication, according to the IMSIS
scale. Wilcoxon tests demonstrated a significant difference
between the level of desired and experienced involvement,
with patients wanting more involvement than they had actu-
ally experienced (Table 3). Table 4 shows the level of support
Table 1 Respondent characteristics
Total sample size Patients Healthcare Professionals
100 104
Gender
Male 34 28
Female 66 76
Age (n = 99a)
B65 56 –
[65 44 –
Type of Healthcare Professional
Doctor – 24
Pharmacist – 30
Nurse – 50
a Age was missing for one patient T
a
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that healthcare professionals reported that they would have for
patient involvement. Descriptive exploration of the results for
each individual item in IMSIS suggests a trend towards
healthcare professionals being more likely to say that they
would support patient involvement than patients wanting such
involvement. This is illustrated further in Fig. 1.
Table 5 and Fig. 2 shows patients’ and healthcare pro-
fessionals’ preferences regarding who should make deci-
sions about their medication, according to the control
preference scale. Once again, there appeared to be a trend
towards healthcare professionals reporting a preference for
greater patient involvement in decision making than
patients had themselves.
Internal reliability of instruments used
For both scales (IMSIS and the control preference scale),
patients’ data showed good internal consistency (Cronbach’s
alpha [0.7) suggesting it was appropriate to sum the indi-
vidual items within the scale concerned to give overall scores
for each scale for the remaining analysis (Table 6). However,
the healthcare professionals’ data did not show the same level
of internal consistency for either scale (Cronbach’s alpha
\0.7); therefore in the remainder of the analysis, we consider
healthcare professionals’ responses to each individual item
rather than considering an overall score for each scale.
Association between preference for general
involvement with inpatient medication
and involvement in decision making
For patients, there was a weak correlation between IMSIS
scores and those for the control preference scale
Table 3 Differences between desired and experienced patient
involvement in different aspects of medication safety while in hos-
pital, according to the IMSIS scale
Statements Test Significance
I have looked at my drug chart
while in hospital versus I
would like to look at my drug
chart while in hospital
Related samples-
Wilcoxon Signed
Rank Test
p \ 0.001
I have asked questions about
my medicines while in
hospital versus I would like
to ask questions about my
medicines while in hospital
I have kept and administered
my medicines while in
hospital versus I would like
to keep and administer my
own medicines while in
hospital
Items measuring desired involvement without a matching item for
experienced involvement not included
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Fig. 1 Preferences for inpatient
involvement with medication
according to the IMSIS scale.
HCPs: health care professionals
Table 5 Patients’ and healthcare professionals’ preferences for involvement in decisions regarding their medication (adapted Control Preference
Scale)
Starting a new medicine Changing the dose of a
medicine that the patient
is already taking
Stopping a medicine
Patient
(n = 100)
Healthcare
professionals
(n = 104)
Patient
(n = 100)
Healthcare
professionals
(n = 104)
Patient
(n = 100)
Healthcare
professionals
(n = 104)
Patient alone 3 9 2 7 2 6
Mostly patient 8 30 11 16 10 13
Doctor (or other healthcare professional) and patient
equally
47 50 45 52 46 45
Mostly Doctor (or other healthcare professional) 24 9 26 20 30 27
Doctor (or other healthcare professional) alone 18 2 16 5 12 9
Total (%) 100 100 100 100 100 100
Fig. 2 Preferences for decision
making when starting a new
medicine using the adapted
control preference scale. HCPs:
health care professionals
662 Int J Clin Pharm (2014) 36:657–666
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(Spearman’s correlation coefficient = 0.41, p \ 0.001). It
was not appropriate to carry out this correlation test for
healthcare professionals as Cronbach’s alpha suggested
internal reliability for each scale to be low.
Associations between patient involvement and age/
gender
Mann–Whitney U tests demonstrated that female patients
(p = 0.003) and patients 65 and under (p = 0.002) had
significantly higher scores for overall desired and experi-
enced involvement with their medication in hospital than
males and those over 65 respectively (Table 7). Females
(p \ 0.001) and those 65 and under (p \ 0.001) were also
more likely to want to be involved in decision making
regarding medicines (Table 8).
Associations between healthcare professional support
for patient involvement and gender/healthcare
professional type
When individual items were tested, there were few asso-
ciations between healthcare professional support for patient
involvement with gender or healthcare professional type.
However, Kruskal–Wallis (Table 9) and Mann–Whitney U
tests showed that both pharmacists and nurses were sig-
nificantly more likely to report that they would support
patients asking questions about their medicines and self
administering their own medicines than doctors
(p \ 0.001).
Barriers to patient involvement
Comments spontaneously added by respondents to the
questionnaire or stated verbally to the researcher provided
preliminary data regarding some of the barriers to patients
being more involved with their medicines.
When patients were asked (1) if they would check with a
healthcare professional if they thought one or more of their
medicines may have been forgotten or (2) they might be
being given the wrong medicine, two expressed the opinion
that they trusted the healthcare professionals’ expertise and
would not challenge them.
One patient reported that patients’ medicines may be
changed or stopped while in hospital and that they may not
have enough knowledge to self-administer their own
medicines.
Three healthcare professionals cited patients’ lack of
cognitive ability and one cited patients’ limited English as
barriers to patient involvement. One nurse expressed the
view that he did not have enough information about self
administration of medicines to say whether or not he would
support this. Some doctors reported that they would not
like to be personally involved with self administration as
they had other demands on their time; they would prefer
nurses to take the lead on this.
Discussion
Both patients and healthcare professionals reported that
they supported patient involvement in medication and
medication safety. This supports the findings of Davis et al.
[12, 17] when exploring patients’ and healthcare profes-
sionals’ views on patients general involvement in health-
care and safety and those of Schwappach and Wernli [14]
Table 6 Internal reliability of instruments used
Scale Patients Healthcare
professionals
Cronbach’s Alpha
IMSIS 0.733 0.574
Adapted control preference scale 0.857 0.665
Table 7 Comparisons between gender and age groups for patients’
IMSIS scale (Mann–Whitney U tests)
Total sample (n = 100) Mean Standard deviation p value*
20.89 5.308
Gender
Male (n = 34) 23.21 4.663 0.003
Female (n = 66) 19.70 5.256
Age
B65 (n = 56) 19.52 5.350 0.002
65\ (n = 43) 22.84 4.629
* Asymptotic significance values are displayed. The significance level
is 0.05
The lower the score, the greater the involvement
Table 8 Comparisons between gender and age groups for patients’
responses to the adapted Control Preference Scale (Mann–Whitney U
tests)
Total sample (n = 100) Mean Standard deviation p value*
10.29 2.500
Overall score for involvement with decisions
Gender
Male (n = 34) 11.44 2.048 \0.001
Female (n = 66) 9.70 2.517
Age
B65 (n = 56) 9.50 2.296 \0.001
65\ (n = 43) 11.33 2.427
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when investigating chemotherapy patients’ engagement in
medical error prevention. However, Davis et al. [12] found
that patients reported lower willingness to notify doctors of
problems or errors than to ask factual questions, but a
higher willingness to notify nurses of errors than to ask
factual questions. Other studies have shown that patients
are more willing to participate in behaviours that were less
challenging [14, 24]. In our study, a similar proportion of
patients wanted to ask questions about their medicines as
said they would challenge a healthcare professional if they
thought an error was being made. The reason for the dif-
ference in findings may be due to the fact that our study
asked about healthcare professionals in general, rather than
asking separately about doctors, nurses and pharmacists.
Female patients and those 65 and under wanted signif-
icantly more involvement in medication and medication
safety than males and those over 65. Findings from pre-
vious studies regarding the association between age and
gender and preferences for involvement in healthcare
safety have been inconclusive [21]. However, the finding
that younger patients have higher preference for involve-
ment in decisions about medicines is consistent with other
research [23, 25]. Previous research has also shown that
younger patients are more likely to have a preference
towards self administration of medicines in hospital [23].
Previous findings concerning gender and preference for
involvement in decision making have been mixed [23, 25].
However, all studies that have identified an association
with gender have concluded that women are the more
likely to prefer a more active role [25]. In addition, female
patients have been shown to be more likely to show a
preference towards self administration of medication in
hospitals [26].
Few associations were found between healthcare pro-
fessional type and gender, and their preference for
involvement. However, pharmacists and nurses were sig-
nificantly more likely to support patients asking questions
and self administering their medicines than doctors. Davis
et al. [17] found that nurses were more likely to support
patient involvement in safety than doctors.
There was a descriptive trend towards healthcare pro-
fessionals reporting being more supportive of patient
involvement with medication than patients in the individual
items of both the IMSIS and control preference scales.
Davis et al. [17] found that doctors were more likely to
support patient involvement in safety as healthcare pro-
fessionals than they would involve themselves as patients,
although this effect was not observed for nurses.
Healthcare professionals showed less variation than
patients in which specific patient involvement behaviours
they strongly supported (Tables 2, 4). Whilst both the
IMISS and control preference scale had good internal
reliability for patients, neither scale showed good internal
reliability for healthcare professionals, suggesting that
healthcare professionals’ beliefs may not form one scale.
This is the first study we are aware of where the control
preference scale had been used for healthcare profession-
als. The results suggest that it may not be appropriate to
group the items as one scale in analysis.
Strengths and limitations
Our study reported important exploratory findings regard-
ing patients’ and healthcare professionals’ views on patient
involvement in medication safety while in hospital. Unlike
many studies in this field we included pharmacists as well
as doctors and nurses. Limitations included that it was
carried out in one trust and convenience sampling was
used. However, patients were recruited from a variety of
ward types and the response rates were mostly very high.
The response rate for pharmacists was lower as fewer were
present on the wards at the time of our researcher’s visits
and they therefore generally had to be recruited via email
rather than in person. However, they were not likely to
have represented a dramatically different range of spe-
cialties to healthcare professionals recruited on the wards
because most pharmacists in the Trust each provide ser-
vices to a wide range of wards. For the same reason, we do
not have data on the total number of nurses and doctors
working on the study wards and are therefore unable to
Table 9 Comparisons among healthcare professional groups in terms of their support for patients asking questions about their medicines and
self-administering (Kruskal–Wallis tests)
Statement Mean ranks Chi square
statistic
Degrees
of freedom
p value
I would support patients asking questions
about their medicines while in hospital’
Doctor 69.13 20.479 2 \0.001
Pharmacist 42.20
Nurse 50.70
‘I would support patients in self administering
their own medicines while in hospital’
Doctor 70.98 16.264 2 \0.001
Pharmacist 40.45
Nurse 49.78
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calculate the proportion of these who completed our
questionnaire. The views of patients who were too unwell
to participate or did not speak English were not repre-
sented. Numbers for each healthcare professional group are
relatively low, precluding anything other than exploratory
analysis. Another limitation was that some doctors
appeared to interpret supporting patients in self adminis-
tration of medicines as personally setting up patients for
self administration rather than being generally in support of
the principle. This may have made their support appear
lower than it was. None of the doctors interpreted the
questionnaire in that way during our piloting so this issue
was not identified at that stage.
Implications for practice
The gap between patients’ preferred and experienced
involvement with inpatient medication needs to be
addressed. Clinical pharmacists are medication experts
with direct contact with patients and thus potentially have
an important role to play in closing the gap. A high pro-
portion of healthcare professionals state that they would
support patients in being involved with their medication
while in hospital, but they need to find ways to encourage
this in practice. Davis et al. [12] have shown that patients
are more likely to participate in safety behaviours if
encouraged to do so by healthcare professionals. More
research is needed to understand the barriers to involving
patients with their medication while in hospital and inter-
ventions should be developed to facilitate involvement. As
a follow up to this study, we are planning to conduct an in
depth qualitative study to address these issues.
Conclusion
The majority of patients and healthcare professionals were
supportive of hospital inpatients being involved with their
medication. However there was a significant gap between
this desire for patient involvement and what was reported
to be experienced by patients in practice. Female patients
and those under 65 wanted a significantly higher level of
involvement with their medication than males and those
over 65. This finding needs to be taken into consideration
when developing interventions. Few associations were
found between healthcare professional support for
involvement and their profession and gender. However,
pharmacists and nurses were significantly more likely to
support patients asking questions about their medicines and
self administering their own medicines than doctors.
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